- Home
- LEGN vs MASI Comparison
LEGN vs MASI Comparison
Compare LEGN & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LEGN | MASI |
|---|---|---|
| Founded | 2014 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 7.6B |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | LEGN | MASI |
|---|---|---|
| Price | $21.07 | $137.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | $69.58 | ★ $188.80 |
| AVG Volume (30 Days) | ★ 2.5M | 758.7K |
| Earning Date | 11-12-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $909,045,000.00 | ★ $2,182,000,000.00 |
| Revenue This Year | $68.52 | N/A |
| Revenue Next Year | $48.63 | $6.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 74.75 | 38.48 |
| 52 Week Low | $20.26 | $125.94 |
| 52 Week High | $45.30 | $194.88 |
Technical Indicators
Market Signals| Indicator | LEGN | MASI |
|---|---|---|
| Relative Strength Index (RSI) | 31.83 | 50.19 |
| Support Level | $21.19 | $125.94 |
| Resistance Level | $22.07 | $131.95 |
| Average True Range (ATR) | 0.77 | 3.55 |
| MACD | 0.11 | 0.25 |
| Stochastic Oscillator | 25.71 | 88.78 |
Price Performance
Historical ComparisonAbout LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About MASI Masimo Corporation
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.